hydroxyl radical has been researched along with n-vinyl-2-pyrrolidinone in 3 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (n-vinyl-2-pyrrolidinone) | Trials (n-vinyl-2-pyrrolidinone) | Recent Studies (post-2010) (n-vinyl-2-pyrrolidinone) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 7,533 | 228 | 2,213 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Arima, H; Hiratsuka, M; Hirayama, F; Iohara, D; Motoyama, K; Takeshita, K; Uekama, K | 1 |
| Guan, X; Hu, Y; Li, Y; Mei, L | 1 |
| Chen, C; Chen, Y; He, L; Liu, H; Liu, X; Ouyang, Y; Sun, Y; Tan, Y; Xu, T; Zhao, S | 1 |
3 other study(ies) available for hydroxyl radical and n-vinyl-2-pyrrolidinone
| Article | Year |
|---|---|
Evaluation of photodynamic activity of C60/2-hydroxypropyl-β-cyclodextrin nanoparticles.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Stability; Electron Spin Resonance Spectroscopy; Fullerenes; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxyl Radical; Nanoparticles; Nanotechnology; Particle Size; Photochemotherapy; Photosensitizing Agents; Povidone; Singlet Oxygen; Superoxides; Technology, Pharmaceutical; Time Factors | 2012 |
Ellagic acid solid dispersion: Characterization and bioactivity in the hydroxyl radical oxidation system.
Topics: Ellagic Acid; Hydroxyl Radical; Povidone; Solubility; Spectroscopy, Fourier Transform Infrared | 2021 |
Sorafenib-Loaded Copper Peroxide Nanoparticles with Redox Balance Disrupting Capacity for Enhanced Chemodynamic Therapy against Tumor Cells.
Topics: Cell Line, Tumor; Copper; Glutathione; Humans; Hydrogen Peroxide; Hydroxyl Radical; Lipid Peroxides; Nanoparticles; Neoplasms; Oxidation-Reduction; Peroxides; Povidone; Sorafenib; Tumor Microenvironment | 2022 |